Style | Citing Format |
---|---|
MLA | Shahi F, et al.. "The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran." International Journal of Hematology-Oncology and Stem Cell Research, vol. 17, no. 2, 2023, pp. 89-99. |
APA | Shahi F, Safaee R, Fekrvand S, Fathi F, Dabiri MR, Abdollahi A, Hosseini H (2023). The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran. International Journal of Hematology-Oncology and Stem Cell Research, 17(2), 89-99. |
Chicago | Shahi F, Safaee R, Fekrvand S, Fathi F, Dabiri MR, Abdollahi A, Hosseini H. "The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran." International Journal of Hematology-Oncology and Stem Cell Research 17, no. 2 (2023): 89-99. |
Harvard | Shahi F et al. (2023) 'The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran', International Journal of Hematology-Oncology and Stem Cell Research, 17(2), pp. 89-99. |
Vancouver | Shahi F, Safaee R, Fekrvand S, Fathi F, Dabiri MR, Abdollahi A, et al.. The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran. International Journal of Hematology-Oncology and Stem Cell Research. 2023;17(2):89-99. |
BibTex | @article{ author = {Shahi F and Safaee R and Fekrvand S and Fathi F and Dabiri MR and Abdollahi A and Hosseini H}, title = {The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran}, journal = {International Journal of Hematology-Oncology and Stem Cell Research}, volume = {17}, number = {2}, pages = {89-99}, year = {2023} } |
RIS | TY - JOUR AU - Shahi F AU - Safaee R AU - Fekrvand S AU - Fathi F AU - Dabiri MR AU - Abdollahi A AU - Hosseini H TI - The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran JO - International Journal of Hematology-Oncology and Stem Cell Research VL - 17 IS - 2 SP - 89 EP - 99 PY - 2023 ER - |